Literature DB >> 23498063

Androgen-deprivation therapy and cardiovascular harm: let's not throw out the baby with the bathwater.

Paul L Nguyen1.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23498063     DOI： 10.1016/j.eururo.2013.03.002

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  3 in total

1.  Cardiovascular toxicities of androgen deprivation therapy in Asian men with localized prostate cancer after curative radiotherapy: a registry-based observational study.

Authors:  Youquan Li; Whee Sze Ong; Ma Than Than Shwe; Nelson Ling Fung Yit; Sheriff Zhan Hong Quek; Eric Pei Ping Pang; Wen Shen Looi; Wen Long Nei; Michael Lian Chek Wang; Melvin Lee Kiang Chua; Terence Wee Kiat Tan; Eu Tiong Chua; Choon Ta Ng; Jeffrey Kit Loong Tuan
Journal:  Cardiooncology       Date:  2022-03-14

Review 2.  Cardiovascular effects of hormone therapy for prostate cancer.

Authors:  Jason F Lester; Malcolm D Mason
Journal:  Drug Healthc Patient Saf       Date:  2015-07-23

3.  Androgen deprivation therapy and cardiovascular risk in chinese patients with nonmetastatic carcinoma of prostate.

Authors:  Gang Huang; Chun-Yip Yeung; Ka Kui Lee; Jianxiong Liu; Kwan Lun Ho; Ming-Kwong Yiu; Karen Siu-Ling Lam; Hung-Fat Tse; Thomas Yau; Chung-Wah Siu
Journal:  J Oncol       Date:  2014-04-07       Impact factor: 4.375
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.